Jazz Pharmaceuticals PLC at RBC Capital Markets Global Healthcare Conference Transcript
Good morning, with a great first session of the conference. We've got Jazz with us represented by Rob, who's the Head of R&D and Chief Commercial Officer; and Jack Spinks, who's the Director of IR. So thanks for being here.
Just one correction. I'm the Chief Medical Officer not Chief Commercial.
Sorry, Chief Medical Officer and Head of buyer. Yes. Saying my swim way. Yes, I wanted to spend most of today's session talking about zanidatamab where you've got some exciting data, and it's a core part of your program. So maybe just by way of a brief introduction of the molecule.
And can you talk to us about what makes it unique and sort of some of the data that's been emerging that suggests that this is a really unique and differentiated HER2 approach? SP434430351.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
